‘Inlyta’ applied to national health insurance service this July

Published: 2018-06-29 16:29:00
Updated: 2018-06-29 16:42:51

‘Inlyta Tab,’ a targeted therapy for renal cancer, will be applied to the national health insurance service this July.

Drug prices of Simponi, a rheumatoid arthritis therapy, and Soliris, a paroxysmal nocturnal hemoglobinuria(PNH) therapy, will get cut due to extended indications.

The Ministry ...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.